Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Astermark

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 4, 2017
Comparative burden of arthropathy in mild haemophilia: a register-based study in SwedenM Osooli, S Lövdahl, K Steen Carlsson, et al.
Journal of Thrombosis and Haemostasis : JTH|October 13, 2009
Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia AA Pavlova, D Delev, S Lacroix-Desmazes, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2008
European principles of haemophilia careB T Colvin, J Astermark, K Fischer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2007
Impact of different inhibitor reactivities with commercial factor VIII concentrates on thrombin generationG L Salvagno, J Astermark, M Ekman, et al.
Annals of the New York Academy of Sciences|January 1, 1991
Epidermal growth factor-like domains in the vitamin K-dependent clotting factors. Some structure-function relationshipsJ Stenflo, A K Ohlin, E Persson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 11, 2017
The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA registerM Osooli, K Steen Carlsson, F Baghaei, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 14, 2011
Recommendations for assessment, monitoring and follow-up of patients with haemophiliaP de Moerloose, K Fischer, T Lambert, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 14, 2014
Managing haemophilia for life: 4th Haemophilia Global SummitJ Astermark, G Dolan, T Hilberg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2002
Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimenK Fischer, J Astermark, J G van der Bom, et al.
Thrombosis Research|October 23, 2016
Current view and outcome of ITI therapy - A change over time?K Holstein, A Batorova, M Carvalho, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 4, 2017
Comparative burden of arthropathy in mild haemophilia: a register-based study in SwedenM Osooli, S Lövdahl, K Steen Carlsson, et al.
Journal of Thrombosis and Haemostasis : JTH|October 13, 2009
Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia AA Pavlova, D Delev, S Lacroix-Desmazes, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2008
European principles of haemophilia careB T Colvin, J Astermark, K Fischer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2007
Impact of different inhibitor reactivities with commercial factor VIII concentrates on thrombin generationG L Salvagno, J Astermark, M Ekman, et al.
Annals of the New York Academy of Sciences|January 1, 1991
Epidermal growth factor-like domains in the vitamin K-dependent clotting factors. Some structure-function relationshipsJ Stenflo, A K Ohlin, E Persson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 11, 2017
The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA registerM Osooli, K Steen Carlsson, F Baghaei, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 14, 2011
Recommendations for assessment, monitoring and follow-up of patients with haemophiliaP de Moerloose, K Fischer, T Lambert, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 14, 2014
Managing haemophilia for life: 4th Haemophilia Global SummitJ Astermark, G Dolan, T Hilberg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2002
Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimenK Fischer, J Astermark, J G van der Bom, et al.
Thrombosis Research|October 23, 2016
Current view and outcome of ITI therapy - A change over time?K Holstein, A Batorova, M Carvalho, et al.
Pageof 8